接受同步放化疗的局部晚期胸部恶性肿瘤患者淋巴细胞最低点及恢复动态:危及器官限制的建立
Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints.
作者信息
Cheung Ben Man Fei, Yuen Kwok Keung, Luk Mai Yee, Leung Dennis Kwok Chuen, Kong Feng-Ming Spring, Lee Victor Ho-Fun
机构信息
Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
出版信息
Radiother Oncol. 2025 Jun 26;210:111009. doi: 10.1016/j.radonc.2025.111009.
BACKGROUND AND PURPOSE
Radiotherapy-induced-lymphopenia (RIL) worsens outcome in thoracic malignancies on radiotherapy (RT). We hypothesised that post-RT absolute lymphocyte count (ALC) nadir and recovery were independently prognostic for overall survival (OS) and progression-free survival (PFS) in thoracic malignancies following radical chemo-irradiation. We also aimed to determine relevant organs-at-risk (OARs) constraints.
METHODS AND MATERIALS
Two independent cohorts of stage III non-small-cell lung cancer (NSCLC) and stage II to III oesophageal cancer (EC) patients receiving chemo-irradiation from 2013 to 2022 were analysed. ALC nadir was defined as the lowest ALC on RT. ALC recovery index (ARI) was the ALC at 6 months/Pre-RT ALC. Effect of ALC nadir and ARI on OS and PFS were evaluated. RT dose of OARs was correlated with ALC nadir and ARI. OAR thresholds were then determined.
RESULTS
High ARI and ALC nadir were independently prognostic of improved OS and PFS for both cohorts. In NSCLC, thoracic spine V35Gy and ribs V35Gy were associated with ARI. Cut-off for thoracic spine V35Gy was 25.5 % while ribs V35Gy cut-off was 6.6 %. Thoracic spine V20Gy and Mean lung dose (MLD) were associated with ALC nadir in NSCLC. MLD cut-off was 16.5 Gy while T spine V20Gy cut off was 25.6 %. For EC, thoracic spine V35Gy was also associated with ARI. Similar to NSCLC, cut-off was 25.7 %. MLD and spleen V5Gy were associated with ALC nadir. MLD and Spleen V5Gy cut-off was 10.6 Gy and 7.2 % respectively.
CONCLUSION
Post-RT lymphocyte nadir and recovery were both important for survival outcomes. Future prospective studies are warranted to validate whether abiding to lymphocyte sparing OARs constraints developed in the current study can improve lymphopenia and outcomes.
背景与目的
放疗诱导的淋巴细胞减少(RIL)会使胸部恶性肿瘤放疗(RT)的预后恶化。我们假设放疗后绝对淋巴细胞计数(ALC)最低点及恢复情况对根治性放化疗后的胸部恶性肿瘤患者的总生存期(OS)和无进展生存期(PFS)具有独立的预后价值。我们还旨在确定相关的危及器官(OAR)限制。
方法与材料
分析了2013年至2022年期间接受放化疗的两个独立队列的III期非小细胞肺癌(NSCLC)和II至III期食管癌(EC)患者。ALC最低点定义为放疗期间的最低ALC。ALC恢复指数(ARI)为放疗前6个月时的ALC/放疗前ALC。评估了ALC最低点和ARI对OS和PFS的影响。OAR的放疗剂量与ALC最低点和ARI相关。然后确定OAR阈值。
结果
高ARI和ALC最低点对两个队列的OS和PFS改善均具有独立的预后价值。在NSCLC中,胸椎V35Gy和肋骨V35Gy与ARI相关。胸椎V35Gy的截止值为25.5%,而肋骨V35Gy的截止值为6.6%。NSCLC中胸椎V20Gy和平均肺剂量(MLD)与ALC最低点相关。MLD的截止值为16.5Gy,胸椎V20Gy的截止值为25.6%。对于EC,胸椎V35Gy也与ARI相关。与NSCLC类似,截止值为25.7%。MLD和脾脏V5Gy与ALC最低点相关。MLD和脾脏V5Gy的截止值分别为10.6Gy和7.2%。
结论
放疗后淋巴细胞最低点和恢复情况对生存结局均很重要。未来有必要进行前瞻性研究,以验证遵循本研究中制定的淋巴细胞保护OAR限制是否能改善淋巴细胞减少及预后。